伊索金基基丁对A375黑色素瘤细胞产生亡作用
Nina Mariano1, Hunter Wolf1, Pavithra Vivekanand1
1Biology Department, Susquehanna University, Selinsgrove, Pennsylvania, United States.
microPublication biology
|October 9, 2024
概括
来自金科比洛巴 (Ginkgo biloba) 的化合物伊索金基基丁 (Isoginkgetin) 有效地降低了A375黑色素瘤细胞活力,并诱导了亡. 这种抗癌效应可能涉及MAPK信号通路,这表明潜在的治疗应用.
科学领域:
- 植物化学 植物化学
- 癌症生物学 癌症生物学
- 分子药理学分子药理学
背景情况:
- 黄酸是植物衍生的二次代谢物,具有潜在的抗癌特性.
- 银杏花产生大量的二次代谢产物,包括双类异黄素 (isoginkgetin).
- 伊索金基基丁已经显示出对各种癌症细胞系的细胞毒性.
研究的目的:
- 为了研究异基丁对A375黑色素瘤细胞的抗癌作用.
- 确定异构素是否会诱导亡,并阐明底层的分子机制.
主要方法:
- 使用XTT测定来评估细胞活力.
- 通过对PARP裂变的Western blot分析检测出了亡.
- 通过检测化ERK,检查了MAPK信号通路的参与.
主要成果:
- 伊索金基基丁治疗导致A375细胞活力的剂量依赖性下降.
- 观察到PARP裂变,这是细胞亡的一个指标,以度依赖的方式观察到.
- 检测到酸化ERK,这表明MAPK信号通路的激活.
结论:
- 伊索金基基丁对A375黑色素瘤细胞具有显著的抗癌作用.
- 该化合物诱导了亡,可能是通过MAPK信号通路的激活.
- 伊索金克基丁代表了在黑色素瘤治疗中进一步研究的有希望的候选人.
相关概念视频
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
The Extrinsic Apoptotic Pathway
6.3K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

